Adjusted Steroids Therapy in Childerens With Idiopathic Nephrotic Syndrome
NCT02649413 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 75
Last updated 2016-01-12
Summary
The initial steroids dose for Nephrotic Syndrome is 60mg/1m2 for 6-4 weeks and the duration of the first steroid course is between 8 weeks to 6 months. The base of the initial dose for steroids Idiopathic nephrotic syndrome been put in the early 70s. In our study the investigators will adjusted the first steroids does to the response day. Our primary end point is : a lower adjusted dose is as good as the fix dose in the first year after diagnosis.
Conditions
- Nephrotic Syndrome, Minimal Change
Interventions
- DRUG
-
Children with Idiopathic Nephrotic syndrome will start 60 mg/m2 prednisone.children that response in 8 days will receive an adjusted dose while the rest of the group will receive the 4 weeks usually dose.
Sponsors & Collaborators
-
Rabin Medical Center
lead OTHER
Principal Investigators
-
Amit Dagan, Dr. · Shneider children Hospital Nephrology Institute
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Year
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-03-31
- Primary Completion
- 2019-04-30
- Completion
- 2019-06-30
Countries
- Israel
Study Locations
More Related Trials
-
Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children
NCT01162005 ·Status: COMPLETED ·Phase: PHASE4
-
Availability Study of ACTH to Treat Children SRNS/SDNS
NCT02972346 ·Status: UNKNOWN ·Phase: NA
-
Adrenocorticotropic Hormone (ACTH) for Frequently Relapsing and Steroid Dependent Nephrotic Syndrome
NCT02132195 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Adrenocorticotropic Hormone on Children With Frequent Relapse or Steroid-dependent Nephrotic Syndrome: a Prospective, Multicenter, Randomized,Open-label Clinical Trial.
NCT06079788 ·Status: RECRUITING ·Phase: PHASE3
-
Study of the Telitacicept in Pediatric Patients With Frequently Relapsing or Steroid Dependent Nephrotic Syndrome
NCT06125405 ·Status: RECRUITING ·Phase: PHASE3
-
Prevelance of Hypercalciuria in Children With Steroid Dependent Nephrotic Syndrome
NCT07194213 ·Status: ACTIVE_NOT_RECRUITING
-
Predictors of Steroid Response in Childhood Nephrotic Syndrome
NCT06130631 ·Status: NOT_YET_RECRUITING
-
Impact of the Administration of Fludrocortisone in Very Premature Infants
NCT03001089 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome
NCT04048161 ·Status: COMPLETED ·Phase: PHASE4
-
Cardiac Performance Evaluation in Children With Steroid Dependent vs Steroid Resistant Nephrotic Syndrome
NCT06622915 ·Status: RECRUITING ·Phase: NA
-
Phase II Pilot Study of Early Cortisol Replacement to Prevent Bronchopulmonary Dysplasia
NCT00004669 ·Status: COMPLETED ·Phase: PHASE2
-
Implementation of a Diagnostic Workflow for Personalized Diagnosis of Nephrotic Syndrome
NCT06325098 ·Status: RECRUITING ·Phase: NA
-
Diagnosis of Central Adrenal Insufficiency in Patients With Prader-Willi Syndrome
NCT02368379 ·Status: COMPLETED ·Phase: NA
-
Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets
NCT00000102 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Biomarkers and Outcome Predictors of Pediatric Nephrotic Syndrome: A Genetic, Transcriptomic, and Secretome Multiomics Study
NCT06792448 ·Status: NOT_YET_RECRUITING
-
Corticosteroids With Placebo Versus Corticosteroids With Propranolol Treatment of Infantile Hemangiomas (IH)
NCT01074437 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome
NCT01444898 ·Status: COMPLETED ·Phase: NA
-
STeroids to REduce Systemic Inflammation After Infant Heart Surgery
NCT03229538 ·Status: COMPLETED ·Phase: PHASE3
-
CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study
NCT03786263 ·Status: UNKNOWN
-
Salt Wasting, Hydro-sodium Balance and Fludrocortisone Requirement in Congenital Adrenal Hyperplasia
NCT03550261 ·Status: COMPLETED
-
Retrospective Evaluation of Carvedilol Versus Captopril in CHF Patients
NCT00249067 ·Status: TERMINATED
-
Cortisol Activity in Patients With Prader-Willi Syndrome and Healthy Controls
NCT00932932 ·Status: COMPLETED
-
A Phase IV, Two-part, Open-label Study Assessing the Pharmacokinetics, Safety and Pharmacodynamics of Spironolactone Oral Suspension in Pediatric Patients
NCT06021860 ·Status: UNKNOWN ·Phase: PHASE4
-
Liothyronine in Children With Single Ventricle Congenital Cardiac Malformations Undergoing the Fontan Procedure
NCT00004828 ·Status: COMPLETED ·Phase: PHASE1
-
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants
NCT00249951 ·Status: COMPLETED ·Phase: PHASE3